Oligodendrocytes, the Forgotten Target of Gene Therapy
If the billions of oligodendrocytes (OLs) populating the central nervous system (CNS) of patients could express their feelings, they would undoubtedly tell gene therapists about their frustration with the other neural cell populations, neurons, microglia, or astrocytes, which have been the favorite...
Saved in:
| Main Authors: | Yasemin Ozgür-Gunes, Catherine Le Stunff, Pierre Bougnères |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/13/23/1973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted steroid delivery for myelin oligodendrocyte glycoprotein antibody-associated rare optic neuritis: Clinical outcome and review literature
by: Shweta Singh, et al.
Published: (2025-04-01) -
Oligodendrocyte arrangement, identification and morphology in the developing superior olivary complex
by: Alina Carola Zacher, et al.
Published: (2025-03-01) -
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
by: Liyan Zhang, et al.
Published: (2024-12-01) -
White Matter Injury in Central Nervous System Disorders
by: Zheng L, et al.
Published: (2025-01-01) -
Unmasking myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): CNS demyelination triggered by TNF-alpha Inhibition in a patient with ankylosing spondylitis
by: Sujatha Baddam, et al.
Published: (2025-05-01)